1
=
-
Oracle Corp
As of May 16, 2026 at 24:00 UTC
Chart
About Oracle Corp
Oracle provides enterprise applications and infrastructure offerings through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used by the world's largest companies for high-volume online transaction processing workloads. Besides databases, Oracle also sells enterprise resource planning platforms and cloud infrastructure that play an increasingly important role in large language model training and inferencing.
Market Statistics
Trading Metrics
How to Buy ORCL
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy ORCL
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesBloom Energy stock has surged 1,300% over the past year, reaching all-time highs this week, driven by strong Q1 earnings (130% YoY revenue growth) and major partnerships with Brookfield and Oracle for data center fuel cell solutions. However, with an $86 billion market cap, the stock's future growth is already priced in, and analysts suggest waiting for a pullback before investing near current highs.
The global Healthcare Revenue Cycle Management (RCM) market is projected to grow from USD 171.58 billion in 2025 to USD 521.0 billion by 2035, at a CAGR of 11.72%. Growth is driven by increasing billing complexity, expanding patient volumes, AI-driven automation adoption, and the shift toward value-based care models. The U.S. market alone is expected to reach USD 234.45 billion by 2035, while Europe's market is projected at USD 133.84 billion.
Oracle is positioned to reach record highs driven by three major catalysts: upcoming fiscal Q4 2026 earnings in early June expected to show 20% revenue growth, the Oracle AI World 2026 conference in October, and long-term monetization of its $500M+ remaining performance obligation (RPO) backlog beginning in 2027. The company benefits from its critical role in cross-cloud AI infrastructure, competing with and supplying hyperscalers like Alphabet, Amazon, and Microsoft. Analyst sentiment has turned bullish with 76% buy-side bias and approximately 40% upside at consensus price targets.
The AI in life sciences market is projected to grow from USD 2.2 billion in 2025 to USD 11.5 billion by 2034, driven by accelerated drug discovery, precision medicine adoption, and increasing healthcare data availability. North America leads with 44.78% market share, while Europe and Asia-Pacific show significant growth potential. Major pharmaceutical and technology companies are investing heavily through partnerships and AI-enabled platforms.
Bloom Energy has surged nearly 200% in 2026, driven by demand from AI data centers needing reliable power. The company's solid oxide fuel cell systems offer faster deployment than nuclear alternatives and have secured major clients including Oracle and Equinix. However, at 128x forward earnings and 28x sales, the stock trades at a premium valuation, warranting cautious entry through dollar-cost averaging.
